09877 JENSCARE-B
- 4.690
- -0.060-1.26%
JENSCARE-B News
Baili Tianheng and Shenzhou Cell turned losses into profits! Many biomedical companies on the Science and Technology Innovation Board ushered in a “good start” in Q1
In the first quarter of 2024, many parts of the country successively issued relevant policies to support the high-quality development of the biomedical industry or innovative pharmaceutical devices to continuously optimize the biomedical innovation environment.
健世科技-B：2023年報
Jenscare Scientific's LuX-Valve Application Not Approved by NMPA, Share Prices Drop 11%
Jenscare Scientific (HKG:9877) said the National Medical Products Administration (NMPA) did not approve LuX-Valve during technical evaluation, according to a Thursday filing on the Hong Kong bourse. L
The decline in Hong Kong shares of Jianshi Technology-B increased to 14%, and the company's LUX-VALVE registration application was not approved by the State Drug Administration.
The decline in Hong Kong shares of Jianshi Technology-B increased to 14%, and the company's LUX-VALVE registration application was not approved by the State Drug Administration.
Changes in Hong Kong stocks | Jianshi Technology-B (09877.HK) surged more than 23%, and global commercialization of the core product LUX-Valve continues to advance
Jianshi Technology-B (09877.HK) rose by more than 23%. As of press release, it rose 18.01% to HK$4.26, with a turnover of HK$444.886 million.
Changes in Hong Kong stocks | Jianshi Technology once surged more than 24% and actively promoted the listing process of its core product LUX-Valve
Gelonghui, April 18 | Jianshi Technology-B (9877.HK) saw a sharp rise in sales today. It rose by more than 24% in the afternoon, hitting a high of HK$4.48, and the turnover exceeded HK$42 million. Recently, Jianshi Technology released its 2023 financial report. The net loss due to mother narrowed to 372 million yuan, and the book capital was 928 million yuan, an increase of 27.6% over the previous year. As far as the company's core products are the LUX-Valve series products of the tricuspid valve interventional catheter replacement system, in the domestic market, the company is currently actively promoting the LUX-Valve listing registration process. LUX-VALVE PL
Shanghai Jiachen Investment Co. , Ltd sold 99,400 H shares of Jianshi Technology-B (09877.HK), worth approximately HK$3.378 million
It was reported on April 16 that according to documents disclosed by the Hong Kong Stock Exchange on April 16, Shanghai Jiachen Investment Co. , Ltd sold $99.94 million H shares worth HK$3.378 million at an average price of HK$3.38 per share on April 11. After the sale, Shanghai Jiachen Investment Co. , Ltd's latest shareholding was 15.444 million shares, and the good position ratio dropped from 5.30% to 4.98%. Make up
Changes in Hong Kong stocks | Jianshi Technology-B (09877) rose more than 22%, the company has abundant cash flow, and the global commercialization of LUX-Valve continues to expand
Jianshi Technology-B (09877) rose by more than 22%. As of press release, it was up 19.05% to HK$4, with a turnover of HK$25.9636 million.
Shanghai Jiachen Investment Co. , Ltd sold 415,000 H shares of Jianshi Technology-B (09877.HK), worth approximately HK$2.086 million
It was reported on April 11 that according to documents disclosed by the Hong Kong Stock Exchange on April 11, Shanghai Jiachen Investment Co. , Ltd sold $415,000 H shares of $Jianshi Technology-B (09877.HK) at an average price of HK$4.84 per share on April 8, worth approximately HK$2.086 million. After the sale, Shanghai Jiachen Investment Co. , Ltd's latest shareholding was 18.352 million shares, and the good position ratio dropped from 6.03% to 5.90%. graphs
Jianshi Technology-B (09877) released annual results with R&D expenditure of 288 million yuan, and the product received wide recognition from around the world
Jianshi Technology-B (09877) announced results for the year ended December 31, 2023, other revenue and revenue...
JENSCARE-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Jianshi Technology-B (09877.HK): Converting 179 million unlisted shares to 179 million H shares of the company
Gelonghui March 25 | Jianshi Technology-B (09877.HK) announced that 178,715,577 unlisted shares will be converted to 178,715,577 H shares on March 25, 2024.
Jenscare Scientific's Mitral Valve Device Completes Enrollment for Confirmatory Clinical Trials
Jenscare Scientific (HKG:9877) said its clip-based TMVr system completed the enrollment for confirmatory clinical trial and the one-month clinical follow-up, according to a Monday Hong Kong bourse fil
Jianshi Technology-B (09877.HK): JensClip completed confirmatory clinical enrollment and one-month follow-up
Gelonghui March 25 | Jianshi Technology-B (09877.HK) announced that recently, JenSclip, a transcatheter mitral valve repair clamping system independently developed by the company to treat severe mitral valve reflux, has completed confirmatory clinical enrollment and completed a one-month clinical follow-up with excellent clinical results. JensClip uses a locking mechanism with a claw wall and is equipped with a structural design that can grip the flap multilaterally, which can effectively reduce reflux. Furthermore, its delivery system design allows doctors to control the instrument in a 360-degree range, which is easy to use and highly flexible. The company is continuing to promote a variety of self-developed innovative medical treatments
Jianshi Technology-B (09877.HK): Complete the full circulation of H shares
Gelonghui March 25 | Jianshi Technology-B (09877.HK) announced that on March 25, 2024, 178,715,577 unlisted shares have been converted to H shares, and the converted H shares will be listed on the Stock Exchange at 9:00 a.m. on March 25, 2024. After the relevant domestic arrangements and procedures are completed, participating domestic shareholders can trade the converted H shares.
Jenscare Scientific Secures HKEX Nod for H Share Circulation
Jenscare Scientific (HKG:9877) said the Hong Kong Stock Exchange's listing committee has granted permission for the conversion of 178,715,577 unlisted company's shares into H shares, according to a Ma
Jianshi Technology-B (09877): The Stock Exchange granted listing approval to implement full circulation of H shares
Jianshi Technology-B (09877) issued an announcement. The company has applied to the Stock Exchange Listing Committee to approve the company in accordance with the conversion and...
Jianshi Technology-B (09877.HK) held a board meeting on March 27 to consider and approve the annual results
Gelonghui March 15 | Jianshi Technology-B (09877.HK) announced that the board of directors meeting will be held on March 27, 2024 (Wednesday) to consider and approve the Group's annual results and announcements for the year ended 31 December 2023, and consider recommending the payment of a final dividend (if any) and other matters.
JENSCARE-B: NOTICE OF BOARD MEETING
Jianshi Technology-B (09877): The China Securities Regulatory Commission issued a filing notice on the company's application for full circulation of H shares
Jianshi Technology-B (09877) issued an announcement. The company recently addressed the China Securities Regulatory Commission on behalf of several shareholders of the company...
Analysis
Price Target
No Data
